Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arclay is a private natural technologies company founded in 2004 that develops and markets mineral-based formulations for health and personal care, agriculture, and environmental applications. Its core platform is Mineral Suspension Technology, also described as Natural Clay Mineral Suspension Technologies, which uses green illite clay and natural spring water to create formulations designed to improve adsorption, absorption, and ionic exchange properties. The company appears to operate commercially as Arclay LLC in the United States, while Arclay Natural Technologies Inc./Incorporated appears in Canadian corporate and Health Canada records. Arclay markets ingredient and finished-product solutions rather than a traditional drug-development pipeline, with offerings spanning personal care actives, cosmetic emulsification, agricultural yield and soil-health products, and at least one Health Canada-listed hand sanitizer product. Overall, it is better characterized as a natural ingredients and applied technology company with health-related activities than as a clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arclay Natural Technologies.